Cargando…
Non-invasive decision support for NSCLC treatment using PET/CT radiomics
Two major treatment strategies employed in non-small cell lung cancer, NSCLC, are tyrosine kinase inhibitors, TKIs, and immune checkpoint inhibitors, ICIs. The choice of strategy is based on heterogeneous biomarkers that can dynamically change during therapy. Thus, there is a compelling need to iden...
Autores principales: | Mu, Wei, Jiang, Lei, Zhang, JianYuan, Shi, Yu, Gray, Jhanelle E., Tunali, Ilke, Gao, Chao, Sun, Yingying, Tian, Jie, Zhao, Xinming, Sun, Xilin, Gillies, Robert J., Schabath, Matthew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567795/ https://www.ncbi.nlm.nih.gov/pubmed/33067442 http://dx.doi.org/10.1038/s41467-020-19116-x |
Ejemplares similares
-
Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images
por: Mu, Wei, et al.
Publicado: (2021) -
Hypoxia-Related Radiomics and Immunotherapy Response: A Multicohort Study of Non-Small Cell Lung Cancer
por: Tunali, Ilke, et al.
Publicado: (2021) -
Radial gradient and radial deviation radiomic features from pre-surgical CT scans are associated with survival among lung adenocarcinoma patients
por: Tunali, Ilke, et al.
Publicado: (2017) -
Peritumoral and intratumoral radiomic features predict survival outcomes among patients diagnosed in lung cancer screening
por: Pérez-Morales, Jaileene, et al.
Publicado: (2020) -
The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges
por: Hu, Qiuyuan, et al.
Publicado: (2023)